Mobile
Search
Advanced search
Multi-criteria search
Who are we ?
Log in
Sign up
Français
English
Kusajili – Clinical trials directory
Send this study to a contact
1
Your personal information
Your name
Your e-mail
Send me a copy
2
Your recipient's information
The name of your contact
Your contact email
3
Your message
Votre message
A 26-week treatment, multi-center, randomized, double-blind, double dummy, parallel-group study to assess the efficacy, safety and tolerability of QVA149 compared to fluticasone/salmeterol in patients with moderate to severe chronic obstructive pulmonary disease https://www.kusajili.fr:443/Trial/8kLplKd8h0m1SuUvtsjsvA%24a-26-week-treatment-multi-center-randomized-double-blind-double-dummy-parallel-group-study-to-assess-the-efficacy-safety-and-to
I have read and accept the terms of use of the site and the Privacy Policy
Send your message